Amedeo Smart

Free Medical Literature Service



Liver Diseases

  Free Subscription

Articles published in
PLoS Genet
    March 2024
  1. SMAGRIS E, Shihanian LM, Mintah IJ, Bigdelou P, et al
    Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse.
    PLoS Genet. 2024;20:e1011179.
    >> Share

  2. MA RK, Tsai PY, Farghli AR, Shumway A, et al
    DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma.
    PLoS Genet. 2024;20:e1011216.
    >> Share

    December 2023
  3. HUANG P, Duan W, Ruan C, Wang L, et al
    NeuroD1-GPX4 signaling leads to ferroptosis resistance in hepatocellular carcinoma.
    PLoS Genet. 2023;19:e1011098.
    >> Share

    January 2023
  4. WATTACHERIL JJ, Raj S, Knowles DA, Greally JM, et al
    Using epigenomics to understand cellular responses to environmental influences in diseases.
    PLoS Genet. 2023;19:e1010567.
    >> Share

    August 2022
  5. KIYOSE H, Nakagawa H, Ono A, Aikata H, et al
    Comprehensive analysis of full-length transcripts reveals novel splicing abnormalities and oncogenic transcripts in liver cancer.
    PLoS Genet. 2022;18:e1010342.
    >> Share

    December 2021
  6. ZHANG W, Wu C, Ni R, Yang Q, et al
    Formimidoyltransferase cyclodeaminase prevents the starvation-induced liver hepatomegaly and dysfunction through downregulating mTORC1.
    PLoS Genet. 2021;17:e1009980.
    >> Share

    June 2021
  7. KESHVARI S, Caruso M, Teakle N, Batoon L, et al
    CSF1R-dependent macrophages control postnatal somatic growth and organ maturation.
    PLoS Genet. 2021;17:e1009605.
    >> Share

  8. CRAIG AJ, Garcia-Lezana T, Ruiz de Galarreta M, Villacorta-Martin C, et al
    Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.
    PLoS Genet. 2021;17:e1009589.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016